SeaSpine Inc.

2302 La Mirada Drive
Vista
California
92081
United States

Tel: 760-727-8399
Fax: 760-727-8809

Website: http://www.seaspine.com/

Email: info@seaspine.com

Show jobs for this employer

68 articles with SeaSpine Inc.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to Beau Standish and 44 non-executive employees in connection with the closing of its acquisition of 7D Surgical.

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will present at the Canaccord Genuity Virtual Musculoskeletal Conference on Thursday, May 20, 2021, beginning at 1:00 PM ET.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended March 31, 2021.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $19.50 per share.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has commenced an underwritten public offering of shares of its common stock.

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the first quarter of 2021 and provided updated revenue guidance for the full-year 2021. The Company also provided additional information regarding the expected financial impact of 7D Surgical in 2021 and 2022.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to nine non-executive employees.

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its Regatta Lateral Plate System.  Marking the first standalone lateral plate for SeaSpine, this Lateral Lumbar Interbody Fusion (LLIF) fixation system allows for multiple plating options, including one, two, and four-hole plates. The addition of

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced preliminary financial results for the fourth quarter and full-year 2020, with U.S. revenues expected to reflect a growth range of 7% to 8%.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended September 30, 2020.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will participate in three upcoming virtual investor conferences.

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the publication of results from a preclinical study, “Examination of the Role of Cells in Commercially Available Cellular Allografts in Spine Fusion: An in vivo animal study,” in The Journal of Bone and Joint Surgery (JBJS). JBJS is the highest regarded scientific publication

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Monday, November 9, 2020. Members of the Company’s management will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET. Individuals interested in listening to t

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the following four abstracts involving its products will be presented at scientific podium presentations at the NASS (North American Spine Society) 2020 Annual Meeting, which will be held virtually. Two of the abstracts received the “Best Paper” designation. The NASS 2020 S

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to seventeen non-executive employees.

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its WaveForm C Interbody Implant System. WaveForm C represents the first of five 3D-printed interbody devices that the Company anticipates launching by mid-2021. This first limited launch marks the one-year anniversary of the SeaSpine and restor

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the Company will present at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020, beginning at 2:40 pm ET.

  • SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Wells Fargo Securities Healthcare Conference on Thursday, September 10, 2020, beginning at 2:00 pm ET. A live and archived webcast of the event will be available from the Investor Relations page of the Company's website at investor.seaspine.com.

  • SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the limited commercial launch of the Explorer™ TO System.